Literature DB >> 21922644

Durable complete response to chemotherapy in an infant with a clival chordoma.

Mohamad M Al-Rahawan1, James D Siebert, Craig S Mitchell, Stephen D Smith.   

Abstract

Chordomas are rare bone tumors of notochord remnants that may occur anywhere within the axial skeleton. The standard of care is complete surgical removal. Proton beam irradiation is commonly used when the tumor is inaccessible or has recurred. Chemotherapy has been used in the treatment of patients at relapse but it has been generally proven ineffective. We report a 7-month-old infant with a clival chordoma who responded to combination chemotherapy consisting of cycles of vincristine/cyclophosphamide/doxorubicin alternating with etoposide/ifosfamide. She has been off chemotherapy for 2 years and is well at age 5.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21922644     DOI: 10.1002/pbc.23297

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

Review 1.  Paediatric Chordomas.

Authors:  Kévin Beccaria; Christian Sainte-Rose; Michel Zerah; Stéphanie Puget
Journal:  Orphanet J Rare Dis       Date:  2015-09-22       Impact factor: 4.123

Review 2.  Skull base chordomas review of current treatment paradigms.

Authors:  Dan Yaniv; Ethan Soudry; Yulia Strenov; Marc A Cohen; Aviram Mizrachi
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2020-04-18

3.  DEPDC1B regulates the progression of human chordoma through UBE2T-mediated ubiquitination of BIRC5.

Authors:  Liang Wang; Liang Tang; Ruijun Xu; Junpeng Ma; Kaibing Tian; Yanbin Liu; Yanghu Lu; Zhen Wu; Xiaodong Zhu
Journal:  Cell Death Dis       Date:  2021-07-30       Impact factor: 9.685

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.